The Effect of Blood Transfusion on Venoarterial PCO2 Difference in Cardiac Surgery
1 other identifier
observational
127
1 country
1
Brief Summary
Venoarterial CO2 difference(delta PCO2), lactate, central venous oxygen saturation(ScVO2) will be recorded in several steps in coronary artery bypass graft and valvular cardiac operations. The patients will be divided into two groups as Transfused, and Non-Transfused Groups observationally. The trend of delta CO2, lactate, ScVO2, postoperative creatinine values, postoperative complications and 28 days mortality will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2017
CompletedFirst Posted
Study publicly available on registry
August 10, 2017
CompletedStudy Start
First participant enrolled
August 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 18, 2017
December 1, 2017
2 months
August 8, 2017
December 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complication
The postoperative neurologic, renal, hepatic, respiratory complications
5 days
Secondary Outcomes (1)
Mortality
28 days
Study Arms (2)
Transfused
Patients who have blood transfusion during cardiac surgery
Not-Transfused
Patients who don't have blood transfusion during cardiac surgery
Interventions
Eligibility Criteria
18-75 years cardiac surgery patients
You may qualify if:
- Elective cardiac surgery, stable cardiac function
You may not qualify if:
- Clinical signs of heart failure, symptomatic cerebral or peripheral failure, uncontrolled diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Turkiye Yuksek Ihtisas Education and Research Hospital
Ankara, 06230, Turkey (Türkiye)
Biospecimen
blood
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Demet Bölükbaşı, Specialist
Turkiye Yuksek Ihtisas Education and Research Hospital
- STUDY DIRECTOR
Sema Turan, Asc prof
Turkiye Yuksek Ihtisas Education and Research Hospital
- STUDY CHAIR
Dilek Kazancı, Asc prof
Turkiye Yuksek Ihtisas Education and Research Hospital
- STUDY CHAIR
Sultan Sevim Yakın, Specialist
Turkiye Yuksek Ihtisas Education and Research Hospital
- STUDY CHAIR
Hija Yazıcıoğlu, Asc Prof
Turkiye Yuksek Ihtisas Education and Research Hospital
- STUDY DIRECTOR
Aysegül Özgok, Prof
Turkiye Yuksek Ihtisas Education and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist doctor
Study Record Dates
First Submitted
August 8, 2017
First Posted
August 10, 2017
Study Start
August 20, 2017
Primary Completion
November 1, 2017
Study Completion
December 1, 2017
Last Updated
December 18, 2017
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share